Health and Healthcare
1067 Articles
Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed…
Short sellers upped their investments in stocks of the most prominent financial firms. Short interest in Bank of America (BAC),…
There is still some conversation about the federal government restricting short-selling activity in certain stocks. The counterargument to these restrictions…
Everyone is trying to figure out who the winners and losers are likely to be under a watered-down healthcare program…
The short interest in most large banks fell very sharply for the period ending May 29, an indication that traders believe…
Reuters: GM and Chrysler said closing dealers was essential to their restructuring. Reuters: The Justice Department is probing big tech…
Investors flock to defensive stocks in times of trouble and and when they worry, assuming they look to stay in…
Twelve of the Fortune 500 CEOs are women. Just twelve. Over the next year, that number is likely to go…
There have been some pretty poor reports on earnings from DJIA components such as Caterpillar Inc. (NYSE: CAT), The Coca-Cola…
Merck released earnings, and cut its forecasts. No wonder. Its Q1 numbers were atrocious. Revenue for the first quarter of…
According to The Wall Street Journal, large US companies held their R&D spending steady in the fourth quarter of last…
At 842, the S&P is pushing near a 25% gains since it bottomed for the year-to-date at 677 on March…
If the rumor mill has any truth to it, then Allergan Inc. (NYSE: GSK) may by the next biotech takeover…
According to Reuters, Obama faces backlash due to AIG (AIG) compensation issues which could set bank his efforts to salvage…
Merck (MRK) is merging with Schering-Plough (SGP) in a deal that the companies say is worth $41.1 billion. In reality,…
Our top personal finance-related articles today. Your wallet will thank you later.